TTX-080

TTX-080 · Tizona Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TTX-080, covering 2026-02-18 to 2026-02-18. Get the full timeline:

Most recent: Clinical Trial Update: TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers [Phase 1]